AtriCure, Inc.

NASDAQ (USD): AtriCure, Inc. (ATRC)

Last Price

23.76

Today's Change

+2.56 (12.09%)

Day's Change

21.14 - 24.64

Trading Volume

2,026,082

Profile
ATRC

Exchange:  NASDAQ Global Market NASDAQ Global Market

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Mr. Michael H. Carrel Mr. Michael H. Carrel

Full Time Employees:  1,200 1,200

IPO Date:  2005-08-05 2005-08-05

CIK:  0001323885 0001323885

ISIN:  US04963C2098 US04963C2098

CUSIP:  04963C209 04963C209

Beta:  1.42 1.42

Last Dividend:  0.00 0.00

Dcf Diff:  42.46 42.46

Dcf:  -18.59 -18.59

Description

AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and the Coolrail device, which enable users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Guided Coagulation System, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure compatible with a range of anatomical shapes. In addition, the company sells Lumitip Dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.

Address

7555 Innovation Way,
Mason, OH 45040, US

513 755 4100

http://www.atricure.com

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment